Page last updated: 2024-08-23

substance p and Diffuse Parenchymal Lung Disease

substance p has been researched along with Diffuse Parenchymal Lung Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuoka, Y; Hatakeyama, A; Hatakeyama, R; Sasaki, H; Sato, A1
Albera, C; Brunelleschi, S; Gagliardi, L; Ghio, P; Lavagno, L; Nicali, R; Pozzi, E; Viano, I1

Other Studies

2 other study(ies) available for substance p and Diffuse Parenchymal Lung Disease

ArticleYear
[Therapy for geriatric syndrome].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006, Mar-10, Volume: 95, Issue:3

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Mental Disorders; Nutritional Support; Pneumonia, Aspiration; Prognosis; Quality of Life; Substance P; Syndrome

2006
Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers or healthy volunteers.
    Neuropeptides, 2000, Volume: 34, Issue:1

    Topics: Adult; Aged; Cells, Cultured; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Monocytes; Neurokinin A; Peptide Fragments; Pulmonary Fibrosis; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3; Reference Values; Sarcoidosis; Smoking; Substance P; Superoxides; Tachykinins

2000